| A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) (NCT05885464) | Beam Therapeutics Inc. | 2023-05-25 |
| A Study of PER-001 in Participants With Open-Angle Glaucoma (NCT05822245) | Perfuse Therapeutics, Inc. | 2023-05-25 |
| Efficacy and Safety Study of HRO350 in Patients with Mild-to-moderate Psoriasis (the 'HeROPA' Study). (NCT06125808) | Arctic Bioscience | 2023-05-25 |
| Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours: (NCT05867615) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2023-05-25 |
| L9LS MAb in Malian Adults (NCT05816330) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-05-25 |
| A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer (NCT05939661) | Osaka University | 2023-05-25 |
| Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma (NCT05821452) | Fujian Medical University Union Hospital | 2023-05-25 |
| A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer (NCT05859750) | Akeso | 2023-05-25 |
| Hydroxyurea and EPO in Sickle Cell Disease (NCT05451940) | Julia Xu | 2023-05-25 |
| Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC (NCT05433116) | Universität des Saarlandes | 2023-05-25 |
| Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury (NCT05317832) | Temple University | 2023-05-25 |
| To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC) (NCT06341660) | Guangzhou Institute of Respiratory Disease | 2023-05-25 |
| Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL (NCT05289687) | Eastern Cooperative Oncology Group | 2023-05-25 |
| 64Cu-GRIP B in Patients With Advanced Malignancies (NCT05888532) | Rahul Aggarwal | 2023-05-25 |
| RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19 (NCT05787327) | Chinese University of Hong Kong | 2023-05-25 |
| Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer. (NCT05660954) | Grupo Espanol de Tumores Neuroendocrinos | 2023-05-25 |
| Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) (NCT05404139) | University Health Network, Toronto | 2023-05-24 |
| HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial (NCT05886465) | Sun Yat-sen University | 2023-05-24 |
| Psilocybin Therapy in Advanced Cancer (NCT05398484) | NYU Langone Health | 2023-05-24 |
| Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma (NCT05600686) | University of California, Davis | 2023-05-24 |
| Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer (NCT05080556) | University College, London | 2023-05-24 |
| A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD) (NCT06697535) | Guangzhou JOYO Pharma Co., Ltd | 2023-05-24 |
| Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS) (NCT05122767) | The Aurum Institute NPC | 2023-05-24 |
| A Trial to Learn How Well REGN9933 Works for Preventing Blood Clots After Knee Replacement Surgery in Adult Participants (NCT05618808) | Regeneron Pharmaceuticals | 2023-05-24 |
| Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial (NCT05408546) | Translational Sciences, Inc. | 2023-05-24 |
| A Trial of GH001 in Patients With Treatment-resistant Depression (NCT05800860) | GH Research Ireland Limited | 2023-05-24 |
| Phase II/III of Recombinant Human Serum Albumin (NCT05858853) | Protgen Ltd | 2023-05-24 |
| The Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography (NCT05861765) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2023-05-24 |
| Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non-small Cell Lung Cancers With Epidermal Growth Factor Receptor Mutations (NCT05299125) | Latin American Cooperative Oncology Group | 2023-05-24 |
| A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia (NCT05865028) | Elizabeth J Franzmann | 2023-05-24 |
| Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease (NCT05888597) | Region Skane | 2023-05-24 |
| PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin (NCT05810870) | MedSIR | 2023-05-24 |
| RP-6306 in Patients With Advanced Cancer (NCT05605509) | Canadian Cancer Trials Group | 2023-05-24 |
| HEALEY ALS Platform Trial - Regimen G DNL343 (NCT05842941) | Merit E. Cudkowicz, MD | 2023-05-24 |
| Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma (NCT05734066) | Jazz Pharmaceuticals | 2023-05-23 |
| FOG-001 in Locally Advanced or Metastatic Solid Tumors (NCT05919264) | Parabilis Medicines, Inc. | 2023-05-23 |
| A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia (NCT05870917) | Institute of Hematology & Blood Diseases Hospital, China | 2023-05-23 |
| ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study (NCT06715592) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2023-05-23 |
| Transcranial Direct Current Stimulation for Post-stroke Fatigue (NCT05816603) | Weill Medical College of Cornell University | 2023-05-23 |
| HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT05553639) | Hookipa Biotech GmbH | 2023-05-23 |
| A Clinical Trial of TQB2618 Injection Combined With Penpulimab Injection and Chemotherapy Versus Penpulimab Injection Combined With Chemotherapy in First-line Treatment of Relapsed/Metastatic Head and Neck Squamous Cell Carcinoma (NCT05783921) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-05-23 |
| A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) (NCT05569759) | Kezar Life Sciences, Inc. | 2023-05-23 |
| A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease (NCT05687890) | Biocity Biopharmaceutics Co., Ltd. | 2023-05-23 |
| A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC) (NCT05675579) | M.D. Anderson Cancer Center | 2023-05-23 |
| A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma (NCT05886634) | Memorial Sloan Kettering Cancer Center | 2023-05-23 |
| A Clinical Trial of STP0404 in Adults With HIV-1 Infection (NCT05869643) | ST Pharm Co., Ltd. | 2023-05-23 |
| An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis (NCT05848258) | Eli Lilly and Company | 2023-05-23 |
| Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo (NCT04237103) | University Hospital, Bordeaux | 2023-05-23 |
| A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized (NCT05799495) | Pfizer | 2023-05-23 |
| A Biomarker Study of ATH434 in Participants With MSA (NCT05864365) | Alterity Therapeutics | 2023-05-23 |
| A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old (NCT02615184) | Takeda | 2023-05-23 |
| Phase IB/II of CPX-351 for Relapse Prevention in AML (NCT04990102) | Georgetown University | 2023-05-22 |
| Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma (NCT05798455) | Tabriz University of Medical Sciences | 2023-05-22 |
| OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION) (NCT05972954) | Omeicos Therapeutics GmbH | 2023-05-22 |
| A Personalized Mind-Body Intervention (MBI) for Improving Sleep Among Women Working in Healthcare (NCT05789212) | Northwell Health | 2023-05-22 |
| Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations (NCT05293626) | Neurophth Therapeutics Inc | 2023-05-22 |
| Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS (NCT05737121) | Vaneltix Pharma, Inc. | 2023-05-22 |
| Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study (NCT06017141) | University of Kansas Medical Center | 2023-05-22 |
| Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy (NCT05747794) | Immutep S.A.S. | 2023-05-22 |
| Cord Blood Transplant in Adults With Blood Cancers (NCT05884333) | Memorial Sloan Kettering Cancer Center | 2023-05-22 |
| ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy (NCT05318027) | Abramson Cancer Center at Penn Medicine | 2023-05-22 |
| EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma (NCT05619913) | Australia New Zealand Gynaecological Oncology Group | 2023-05-22 |
| EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) (NCT06923761) | Grey Wolf Therapeutics | 2023-05-21 |
| Effect of Celery Seed on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion (NCT06061926) | University of Guadalajara | 2023-05-20 |
| Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss (NCT06333600) | Sohag University | 2023-05-20 |
| Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC (NCT05726370) | Dana-Farber Cancer Institute | 2023-05-20 |
| Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed/Refractory Multiple Myeloma (NCT05857982) | Second Affiliated Hospital of Soochow University | 2023-05-20 |
| Neoadjuvant Radiotherapy Combined With Toripalimab for Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT05861557) | Tianjin Medical University General Hospital | 2023-05-20 |
| Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP) (NCT05687500) | Assistance Publique - Hôpitaux de Paris | 2023-05-20 |
| The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma (NCT05841550) | Oslo University Hospital | 2023-05-19 |
| A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN (NCT05856760) | Travere Therapeutics, Inc. | 2023-05-19 |
| REward Processing And Citalopram Study (NCT06017037) | University of Oxford | 2023-05-19 |
| Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease (NCT05894343) | MeiraGTx, LLC | 2023-05-19 |
| Efficacy and Safety of Anakinra in Acute Respiratory Distress Syndrome (NCT05914454) | Azienda Sanitaria-Universitaria Integrata di Udine | 2023-05-19 |
| ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study (NCT05596409) | Stemline Therapeutics, Inc. | 2023-05-19 |
| Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy (NCT05757219) | H. Lee Moffitt Cancer Center and Research Institute | 2023-05-19 |
| A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (NCT05683171) | M.D. Anderson Cancer Center | 2023-05-19 |
| Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss (NCT06090318) | Rain Oncology Inc | 2023-05-19 |
| StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2 (NCT05439031) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-05-19 |
| A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy (NCT05938023) | Percheron Therapeutics | 2023-05-18 |
| Premedication to Reduce Amivantamab Associated Infusion Related Reactions (NCT05663866) | Janssen Research & Development, LLC | 2023-05-18 |
| Baricitinib for Reduction of HIV - CNS (NCT05452564) | William Tyor | 2023-05-18 |
| Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study (NCT05718869) | City of Hope Medical Center | 2023-05-18 |
| Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial (NCT05378113) | Emory University | 2023-05-18 |
| A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer (NCT05908734) | Janssen Research & Development, LLC | 2023-05-18 |
| Siplizumab in T1DM (NCT05574335) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-05-18 |
| A Study of CM326 in Subjects With Moderate to Severe Asthma (NCT05774340) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2023-05-18 |
| Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment (NCT05580861) | Assistance Publique - Hôpitaux de Paris | 2023-05-17 |
| A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease (NCT05791864) | Tern Therapeutics, LLC | 2023-05-17 |
| Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer (NCT05806931) | Rutgers, The State University of New Jersey | 2023-05-17 |
| A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression (NCT06229977) | Rodrigo Machado-Vieira, MD, PhD, MSc | 2023-05-17 |
| Addition of Aspirin to Standard of Care in Oral Cancer (NCT05865548) | Banaras Hindu University | 2023-05-17 |
| Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME) (NCT05900648) | M.D. Anderson Cancer Center | 2023-05-17 |
| A Study of PM8002 in Combination With Chemotherapy in Patients With NEN (NCT05879055) | Biotheus Inc. | 2023-05-17 |
| A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults (NCT05901636) | Janssen Vaccines & Prevention B.V. | 2023-05-17 |
| Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients (NCT05062889) | Gruppo Oncologico del Nord-Ovest | 2023-05-17 |
| PG2 Injection for the Treatment of moderate-to Severe Fatigue in Breast Cancer Patients (NCT05440227) | PhytoHealth Corporation | 2023-05-17 |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL (NCT05748171) | Pfizer | 2023-05-17 |
| SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy (NCT05586581) | Yale University | 2023-05-17 |
| A Study of QY101 Ointment in Subjects With Plaque Psoriasis (NCT06170840) | E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | 2023-05-17 |